The ten elements of lung cancer prevention and treatment
1.The key to prevention is to stay away from tobacco (including passive smoking).
The best prevention is not to smoke, quit smoking and stay away from passive smoke pollution. At the same time, we should pay attention to the green decoration of the house, the ventilation method of the kitchen and scientific cooking methods.
2, early diagnosis is important
Adults should join health checkups every year as usual, and chest X-ray front and side examinations should be performed during health checkups. Smokers with 30 years of smoking history should preferably have a low-dose spiral CT scan of the chest to help detect lesions at an early stage. Meanwhile, clinical symptoms of lung cancer such as irritating cough, bloody sputum, chest pain, hoarseness, etc. should be emphasized.
3.Scientific medical treatment for lung cancer
Don’t trust “pseudoscience”! Once lung cancer is diagnosed, you must go to a regular hospital, preferably to the thoracic surgery, oncology and respiratory medicine departments of lung cancer treatment centers or specialized hospitals. Don’t trust pseudoscience such as “ancestral secret recipe” and “special results”, and don’t put your hope on those health care products.
4.Lung cancer diagnosis should be staged first and treated later
Before lung cancer treatment, chest CT, cranial MRI, fiberoptic bronchoscopy, whole body bone scan, abdominal ultrasound or abdominal CT, blood tumor marker test must be done. The clinical stage should be clearly defined before starting treatment, and surgery should be decided after excluding extra-pulmonary metastasis! Never “rush” surgery! Because the treatment strategies of lung cancer with different stages are different, the treatment results are also different.
5.Surgery has compliance
Stage I, II and IIIa non-small cell lung cancer can benefit from surgery, while stage IV lung cancer should not be operated in principle. In recent years, with the popularization of minimally invasive thoracic surgery skills and the application of effective chemotherapeutic drugs and targeted drugs, extended resection surgery for lung cancer is no longer advocated.
6.There are first-line chemotherapy and second-line chemotherapy for lung cancer
First-line chemotherapy drugs: Noviben, Teso, Kinsei and Tysodi plus platinum drugs (cisplatin, carboplatin), second-line chemotherapy drugs: Tysodi, Lipitor, Erythroxel and Troche. Chemotherapy with the application of drugs such as Ketorol can prevent and control nausea and vomiting caused by chemotherapy drugs, and drugs such as Wheal blood can improve the leukopenia caused by chemotherapy with bone marrow suppression.
7.Lung cancer radiotherapy skills have been greatly improved
There are new technologies such as conformal intensity modulated radiotherapy, Gamma knife and X-knife.
8.Targeted therapy is a miracle
In recent years, targeted therapy drugs have brought good news to thousands of non-small cell lung cancer patients. It has been three years since the launch of ERSA in China, and one year since the launch of Tricare in China. It has brought hope for survival to patients who failed chemotherapy treatment and middle-aged and elderly lung cancer patients who cannot tolerate chemotherapy. We hope that the medical insurance department will start the “green channel” as soon as possible and include it in the medical insurance reimbursement list.
9.Cautiously choose new lung cancer treatment skills
In recent years, some investors have invested in major hospitals to purchase new configurations of lung cancer treatment and use commercial skills to attract oncology departments of major hospitals to introduce lung cancer patients to them. Most of them are oncologists who are the gatekeepers, and a few medical institutions are aiming at profit-making, without professional oncologists, comprehensive treatment skills and medical quality assurance. Patients should be careful in choosing the so-called “new skills”.
10.Lung cancer emphasizes multidisciplinary comprehensive treatment
With the continuous accumulation of understanding of tumor cell biology, clinical information and clinical experience, experts and scholars in lung cancer emphasize more on multidisciplinary and comprehensive treatment for lung cancer! Small cell lung cancer is treated with chemotherapy-based multidisciplinary comprehensive treatment, and local early and mid-stage non-small cell lung cancer is treated with surgery-based multidisciplinary comprehensive treatment. Combined with the results of years of clinical research, it has been shown that effective preoperative neoadjuvant chemotherapy and postoperative adjuvant chemotherapy can extend the five-year survival rate of non-small cell lung cancer.